Key topics

1. Understand how pricing and reimbursement frameworks are evolving across MENA
   • Where systems are converging
   • Where fragmentation remains structural
2. Assess the real role of HTA, evidence, and value frameworks in MENA decision-making
   • What is aspirational vs operational
   • How evidence is actually used in negotiations
3. Navigate affordability pressures without undermining access to innovation
   • Tendering, reference pricing, and procurement dynamics
   • Budget control vs long-term system sustainability
4. Translate pricing approval into real patient access
   • Addressing delays, bottlenecks, and implementation gaps
   • Public vs private market dynamics
5. Align global pricing strategy with regional autonomy
   • Managing international price corridors
   • Empowering regional decision-making within global constraints

Who should attend

This summit is designed for senior decision-makers with direct responsibility for pricing, reimbursement, access, or policy engagement in MENA, including:

• Heads / Directors of Market Access & Pricing (MENA, GCC, MEA)
• HEOR, Value & Policy leaders
• Government pricing & reimbursement authorities
• National procurement & tendering bodies
• HTA advisors and system architects
• Regional leadership of multinational and local pharmaceutical companies

Target audience

• Pharmaceutical Companies
• Biotech Companies
• Clinical Research Organizations
• International and Regional Health Authorities and Regulators
• Technology Vendors
• Business Process Outsourcing
• Healthcare Systems